Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Hepion Pharmaceuticals's operating income for the twelve months ending Sep 30, 2026 was -$4.17M. For fiscal 2025 it was -$4.16M. The highest annual figure on record is -$1.67M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.16M | – |
| FY2024 | Dec 31, 2024 | -$19.35M | – |
| FY2023 | Dec 31, 2023 | -$48.45M | – |
| FY2022 | Dec 31, 2022 | -$45.49M | – |
| FY2021 | Dec 31, 2021 | -$30.40M | – |
| FY2020 | Dec 31, 2020 | -$20.15M | – |
| FY2019 | Dec 31, 2019 | -$7.77M | – |
| FY2017 | Jun 30, 2017 | -$21.02M | – |
| FY2016 | Jun 30, 2016 | -$20.81M | – |
| FY2015 | Jun 30, 2015 | -$13.96M | – |
| FY2014 | Jun 30, 2014 | -$1.67M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -$1.55M | – |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$1.21M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$798.51K | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$609.68K | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$527.90K | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$1.75M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$1.28M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$1.20M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$4.46M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$8.50M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$5.18M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$10.41M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$10.66M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$14.17M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$13.21M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$9.77M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$8.47M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$20.00M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$7.25M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$9.00M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$8.52M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$6.85M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$6.03M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$4.95M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$6.23M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$4.78M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$4.19M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$2.24M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$1.91M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$1.70M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$1.92M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$5.22M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$4.91M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$6.02M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$4.88M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$5.79M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$4.65M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$5.51M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$4.84M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$5.38M | – |
See a number that looks wrong?